BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19273133)

  • 1. PML nuclear bodies as sites of epigenetic regulation.
    Torok D; Ching RW; Bazett-Jones DP
    Front Biosci (Landmark Ed); 2009 Jan; 14(4):1325-36. PubMed ID: 19273133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes.
    Cho S; Park JS; Kang YK
    J Biol Chem; 2011 Nov; 286(47):41115-24. PubMed ID: 21921037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
    Reineke EL; Kao HY
    Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
    Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
    mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin.
    Kepkay R; Attwood KM; Ziv Y; Shiloh Y; Dellaire G
    Cell Cycle; 2011 Jan; 10(2):308-22. PubMed ID: 21228624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTRAP is a novel PML nuclear bodies-associated protein.
    Xu GL; Pan YK; Wang BY; Huang L; Tian L; Xue JL; Chen JZ; Jia W
    Biochem Biophys Res Commun; 2008 Oct; 375(3):395-8. PubMed ID: 18706885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
    PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
    Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
    J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination.
    Yeung PL; Denissova NG; Nasello C; Hakhverdyan Z; Chen JD; Brenneman MA
    J Cell Biochem; 2012 May; 113(5):1787-99. PubMed ID: 22213200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
    Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
    Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.
    Catez F; Picard C; Held K; Gross S; Rousseau A; Theil D; Sawtell N; Labetoulle M; Lomonte P
    PLoS Pathog; 2012; 8(8):e1002852. PubMed ID: 22912575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
    Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
    J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?
    Borden KL
    Biochim Biophys Acta; 2008 Nov; 1783(11):2145-54. PubMed ID: 18616965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic PML: from molecular regulation to biological functions.
    Jin G; Gao Y; Lin HK
    J Cell Biochem; 2014 May; 115(5):812-8. PubMed ID: 24288198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional connection between Rad51 and PML in homology-directed repair.
    Boichuk S; Hu L; Makielski K; Pandolfi PP; Gjoerup OV
    PLoS One; 2011; 6(10):e25814. PubMed ID: 21998700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML nuclear bodies.
    Lallemand-Breitenbach V; de Thé H
    Cold Spring Harb Perspect Biol; 2010 May; 2(5):a000661. PubMed ID: 20452955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.